MONTREAL, CANADA -- (MARKET WIRE) -- February 07, 2007 -- ART Advanced Research Technologies Inc. (“ART”) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that long-time shareholders and insiders of the ART have committed to reinvest approximately $3.5 million in the treasury of ART at a price of $0.35 per common share, representing a discount of 18% on the market price (five (5) day volume weighted average price) on January 31, 2007, which was reserved with the Toronto Stock Exchange on February 1, 2007. ART expects to close the transaction on or before February 21, 2006. ART intends to use the net proceeds of the financing as working capital and to expand its intellectual property position in the field of optical imaging. This private placement is subject to obtaining all necessary regulatory approvals, including that of the Toronto Stock Exchange. It is made without any financial intermediary.
